<DOC>
	<DOCNO>NCT01600625</DOCNO>
	<brief_summary>One important factor obtain successful outcome treat severe meibomian gland dysfunction ( MGD ) control exist ocular eyelid inflammation . Thus , previous study , topical systemic antibiotic anti-inflammatory function , topical azithromycin , systemic tetracycline , doxycycline minocycline , use treat severe MGD . In study , minocycline few side effect use evaluate effect cytokine level severe MGD . At study initiation , patient complete Ocular Surface Disease Index ( OSDI ) questionnaire ocular surface , tear , meibomian gland evaluation consist fluorescein tear break-up time ( TBUT ) , Schirmer test , corneal conjunctival fluorescein staining , microscopic examination lid margin meibomian gland , tear cytokine level . All measurement except tear cytokine level conduct manner treatment , 1 month , 2 month treatment . Tear cytokine level evaluate treatment 2 month treatment . The aim research determine concentration inflammatory cytokine tear patient MGD compare cytokine level , correspond clinical response , ocular symptom 2 month treatment oral minocycline .</brief_summary>
	<brief_title>Effects Minocycline Cytokine Levels Severe Meibomian Gland Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Minocycline</mesh_term>
	<criteria>patient stage 3 4 meibomian gland dysfunction moderate mark symptom ocular discomfort , itching , photophobia limitation activity moderate severe meibomian gland dysfunction clinical sign mild moderate conjunctival peripheral corneal stain increase conjunctival corneal staining , include central staining increase sign inflammation : moderate severe conjunctival hyperemia , phlyctenulae history previous ocular intraocular surgery evidence acute chronic infection inflammation cornea conjunctiva ocular allergy autoimmune disease history intolerance hypersensitivity component study medication use topical ocular medication wear contact lens study period presence current punctal occlusion pregnancy lactate woman child</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>meibomian gland dysfunction</keyword>
	<keyword>inflammatory tear cytokine</keyword>
	<keyword>minocycline</keyword>
</DOC>